Stem Cell Research & Therapy DOI: 10.1186/s13287-022-02906-z (2022)

Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fbrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.